Alliancebernstein L.P. Veracyte, Inc. Transaction History

Alliancebernstein L.P.

$287 Billion
Q3 2024

A detailed history of Alliancebernstein L.P. transactions in Veracyte, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 96,420 shares of VCYT stock, worth $4.01 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

96,420

Previous 99,420 3.02%

Holding current value

$4.01 Million

Previous $2.15 Million 52.32%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$21.0 - $35.25 $63,000 - $105,750	-3,000 Reduced 3.02%	96,420 $3.28 Million
Q1 2024 May 14, 2024	SELL	$21.0 - $29.1 $41,370 - $57,327	-1,970 Reduced 1.94%	99,420 $2.2 Million
Q4 2023 Feb 14, 2024	BUY	$19.72 - $28.68 $45,356 - $65,964	2,300 Added 2.32%	101,390 $2.79 Million
Q3 2023 Nov 14, 2023	SELL	$22.33 - $29.92 $27,711 - $37,130	-1,241 Reduced 1.24%	99,090 $2.21 Million
Q2 2023 Aug 15, 2023	BUY	$20.96 - $26.99 $470,153 - $605,412	22,431 Added 28.79%	100,331 $2.56 Million
Q1 2022 May 13, 2022	SELL	$21.94 - $42.51 $770,532 - $1.49 Million	-35,120 Reduced 31.07%	77,900 $2.15 Million
Q4 2021 Feb 14, 2022	BUY	$36.09 - $53.79 $1.25 Million - $1.86 Million	34,630 Added 44.18%	113,020 $4.66 Million
Q3 2021 Nov 10, 2021	BUY	$35.62 - $52.97 $3,205 - $4,767	90 Added 0.11%	78,390 $3.64 Million
Q1 2021 May 06, 2021	BUY	$44.47 - $81.38 $31,129 - $56,966	700 Added 0.9%	78,300 $4.21 Million
Q4 2020 Feb 08, 2021	BUY	$32.49 - $61.88 $19,494 - $37,128	600 Added 0.78%	77,600 $3.8 Million
Q3 2020 Nov 12, 2020	BUY	$26.73 - $35.67 $352,836 - $470,844	13,200 Added 20.69%	77,000 $2.5 Million
Q1 2020 May 14, 2020	SELL	$16.13 - $30.17 $16,129 - $30,170	-1,000 Reduced 1.54%	63,800 $1.55 Million
Q4 2019 Feb 18, 2020	BUY	$20.78 - $29.99 $20,780 - $29,990	1,000 Added 1.57%	64,800 $1.81 Million
Q3 2019 Nov 14, 2019	BUY	$23.87 - $30.93 $35,805 - $46,395	1,500 Added 2.41%	63,800 $1.53 Million
Q2 2019 Aug 14, 2019	BUY	$22.1 - $28.56 $704,990 - $911,064	31,900 Added 104.93%	62,300 $1.78 Million
Q1 2019 May 14, 2019	BUY	$12.0 - $25.76 $24,000 - $51,520	2,000 Added 7.04%	30,400 $761,000
Q4 2018 Feb 13, 2019	BUY	$9.15 - $14.85 $138,165 - $224,235	15,100 Added 113.53%	28,400 $357,000
Q3 2018 Nov 08, 2018	BUY	$9.55 - $12.64 $25,785 - $34,128	2,700 Added 25.47%	13,300 $127,000
Q2 2018 Aug 13, 2018	BUY	$5.39 - $9.66 $57,134 - $102,396	10,600 New	10,600 $99,000

Others Institutions Holding VCYT

# of Institutions

307

Shares Held

81.6M

Call Options Held

134K

Put Options Held

13.3K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.97B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Veracyte, Inc. Transaction History